Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.47

-0.44

-0.4

-0.37

Details

Expected EPS

-0.466667

Actual EPS

-0.42

Surprise EPS

0.05

Surprise Percent

+10%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.42 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.